Stanley Erck, Novavax CEO (Lee Jin-wook/Yonhap via AP Images)
July 13, 2022 10:35 AM EDT
Coronavirus

Covid-19 roundup: FDA re­port­ed­ly set to au­tho­rize No­vavax jab; As­traZeneca says its shot just as ef­fec­tive as mR­NA

Tyler Patchen

News Reporter

Though No­vavax has been go­ing down a wind­ing path to get a EUA from the FDA, the Mary­land-based biotech may soon be re­ceiv­ing some good …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

A service from the Financial Times